Amgen has a couple of shots on goal to break into one of the biggest markets…
Tag: Biopharmaceuticals
WSJ News Exclusive | The Hedge Fund That Made a Killing Betting Against Lina Khan
Pentwater Capital predicted that FTC efforts to block big deals would fail.
Blockbuster Cancer Treatment Stymied by Supply Chain—for Now
A cell therapy for multiple myeloma promises to be a major blockbuster for J&J and partner…
Biden FTC’s Antitrust Bark Proves Worse Than Its Bite
The FTC settlement with Amgen will pave the way for more healthcare deal making.
Amgen’s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle
The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8…
FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics
The move gives the agency time to weigh a settlement that would allow the deal to…
Big Pharma Bets Big on China
China remains attractive to global pharmaceutical companies, even as many multinationals are turning their attention elsewhere.
Opinion | Gilead Sciences Is the Target of a Bizarre Legal Theory
A lawsuit claims Gilead should have rolled out a new drug sooner.